From Nature, 6 April 2022:
When Melody Smith began her fellowship in haematology and oncology at the Memorial Sloan Kettering Cancer Center in New York, she had no idea that she would soon be writing her own code, working with computational biologists and analysing faecal samples to understand the microbial composition — or microbiome — of the gut.
Now at Stanford University in California, Smith is one of a growing number of researchers exploring how the complex and diverse populations of microbes in the body — known as the microbiota — influence how people respond to cancer treatments.
“Before I started my training, I wouldn’t have thought much about the microbiome,” Smith says. “But it’s been really interesting to get to know the field and to understand all of the different diseases where the microbiome is shown to be relevant, especially in the field of oncology.” Read more.
Bianca Nogrady 